This inventor holds 65 USPTO granted patents and 70 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Nucleic Acid Sequencing (CPC class G01N). Top assignees: Element Biosciences, Inc., Illumina Corporation, Life Technologies Corporation. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Peabody, MA (US) (2015)
- Carlsbad, CA (US) (2011 - 2023)
- San Diego, CA (US) (2019 - 2024)
Company Filing History:
32 out of 48 
20 out of 1,224 
10 out of 1,896 
Years Active: 2011-2026
Areas of Expertise:
Title: Michael Previte - Innovator in Nucleotide Sequencing Methods
Introduction
Michael Previte, based in San Diego, CA, is an accomplished inventor known for his contributions to the field of biotechnology. With a remarkable portfolio of 54 patents, Previte has made significant strides in the development of nucleotide sequencing methodologies, which have broad applications in genomics and molecular biology.
Latest Patents
Among his latest innovations, Previte has patented methods and systems focusing on nucleotide transient binding for sequencing methods. These compositions enhance the accuracy of deducing sequences of template nucleic acid molecules and facilitate single nucleotide polymorphism (SNP) analyses. His innovative approach relies on the extended transient-binding time of complementary nucleotides, allowing for precise sequencing without incorporating non-complementary nucleotides.
In addition, he has developed optical systems for nucleic acid sequencing that feature advanced fluorescence imaging designs. These designs offer larger fields of view, improved spatial resolution, and faster transitions between image captures, ultimately enhancing throughput and cost-effectiveness in genomic applications.
Career Highlights
Michael Previte's career includes significant roles at reputable biotechnology companies, notably Element Biosciences, Inc. and Illumina Corporation. His work in these organizations has played a pivotal role in advancing sequencing technologies and genomic research.
Collaborations
Throughout his career, Previte has collaborated with esteemed colleagues, including Molly Min He and Matthew William Kellinger. These collaborations highlight the importance of teamwork in driving innovation and achieving breakthroughs in scientific research.
Conclusion
Michael Previte continues to be a leading figure in biotechnology, with his patented technologies paving the way for enhanced nucleic acid sequencing methods. His work not only contributes to scientific advancements but also exemplifies the spirit of innovation that drives the field forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile